Connection

Idris Guessous to Pandemics

This is a "connection" page, showing publications Idris Guessous has written about Pandemics.
Connection Strength

0.062
  1. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
    View in: PubMed
    Score: 0.030
  2. Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic. Prev Med. 2021 09; 150:106696.
    View in: PubMed
    Score: 0.008
  3. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 11 12; 10(11):e040110.
    View in: PubMed
    Score: 0.008
  4. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
    View in: PubMed
    Score: 0.002
  5. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643.
    View in: PubMed
    Score: 0.002
  6. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2021 05; 174(5):723-725.
    View in: PubMed
    Score: 0.002
  7. Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP). Swiss Med Wkly. 2020 11 16; 150:w20398.
    View in: PubMed
    Score: 0.002
  8. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020 Dec; 65(9):1529-1548.
    View in: PubMed
    Score: 0.002
  9. [Telemedicine at the heart of management of the COVID-19 crisis]. Rev Med Suisse. 2020 Sep 16; 16(706):1699-1702.
    View in: PubMed
    Score: 0.002
  10. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
    View in: PubMed
    Score: 0.002
  11. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2021 04; 21(4):e69-e70.
    View in: PubMed
    Score: 0.002
  12. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.